Company / Operating Cash Flow per Share
BIOCRYST PHARMACEUTICALS INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.59
FY2025
5-year range
-$0.87 / $1.59
FY2021-FY2025
Trend
+731.5%
vs FY2024
Sector context
#46 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +731% YoY in FY2025, a notable deviation from the 9-year average annual change of +88%.
Based on SEC 10-K filings.
1.59 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.50 to $1.59 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 212This company $1.59 Sector average $5.28
▼
-69.9% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 731.5% year-over-year.
- Ranks #46 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.59 | +731.5% |
| FY2024 | -$0.25 | +49.2% |
| FY2023 | -$0.50 | +43.1% |
| FY2022 | -$0.87 | -9.7% |
| FY2021 | -$0.79 | +1.7% |
| FY2020 | -$0.81 | -4.2% |
| FY2019 | -$0.77 | +13.6% |
| FY2018 | -$0.90 | -60.9% |
| FY2017 | -$0.56 | +23.5% |
| FY2016 | -$0.73 | -299.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026